Appsilon

Appsilon is a Poland-based technology company focused on regulated life sciences, particularly pharmaceuticals. Founded in 2012, it has grown into a specialist in open-source analytics infrastructure for clinical development. The company delivers R and Python applications, Statistical Computing Environments (SCEs), and package validation frameworks designed to meet GxP compliance requirements. Appsilon works with eight of the world's ten largest pharmaceutical companies, and its engineers contribute to widely-used open-source projects including teal, Rhino, and aNCA—collectively downloaded nearly 500,000 times. The team includes biostatisticians, PhD-level scientists, and developers, selected from 15,000+ annual applicants at a 1% acceptance rate.

Services and capabilities

Appsilon's core offering splits into three tracks. First, clinical applications: Shiny dashboards and R/Python packages built for pharmacovigilance, Data Monitoring Committees (DMCs), clinical trial data analysis, and insight systems. The company has demonstrated ability across prototypes, enterprise apps, and large decision support systems. One case study shows a Shiny app reducing response time from 30 seconds to 3 seconds—a 10x improvement—while cutting data transfer from 8MB to 800KB through server-side optimization.

Second, infrastructure: Appsilon designs and deploys validated Statistical Computing Environments (SCEs) on cloud-native platforms (AWS, Google Cloud, Azure). These standardize R, Python, and SAS workflows with full traceability and audit readiness. The company offers three tiers—Standard (validated R/Python environment with essential clinical data integrations), Advanced (automated package validation, CI/CD modules, regulatory system integrations), and Enterprise Framework (multi-team governance, organization-wide IAM/LIMS integration, customizable security auditing). A documented case study shows one top-50 pharma client achieved $930,000 in annual savings by replacing proprietary tools with a custom Appsilon-designed R and Python platform.

Third, compliance and migration: Appsilon provides GxP-aligned R package validation through Axon.R, an audit-ready framework for open-source R in regulatory submissions. The company also handles SAS-to-R/Python migration with structured team training. On the tooling side, Appsilon builds and maintains open-source frameworks: Rhino (for enterprise Shiny/R development) and Tapyr (modular development for Shiny in Python).

Notable work

Three detailed case studies anchor Appsilon's portfolio. The first involved accelerating clinical trials using teal, Appsilon's contributed open-source Shiny framework; trials shifted from months to weeks for data exploratory app deployment. The second—the $930K savings case—shows how custom R/Python infrastructure replaced SAS and proprietary tools, cutting annual costs significantly while improving scalability. The third documents a top-50 pharma company's migration to a GxP-compliant Posit stack using Kubernetes and Ansible for infrastructure-as-code governance.

Beyond pharma, Appsilon built the Johns Hopkins Lyme Disease App (an award-winning interactive disease explorer) and dashboards for Elkem (a silicon-based materials company), demonstrating Posit Connect infrastructure for cross-site process monitoring. The company counts Boston Medical Center's Health Equity Explorer among recent work.

How they work

Appsilon engages through direct consultation and custom scoping. The website notes 24-hour response times for inquiries. For SCE deployment, the company handles core implementation, enterprise system integrations (IAM, data lakes, LIMS), and long-term operations including validation refreshes. For Shiny work, services include automated data pipeline design, custom application development, security architecture, user-centric interface design, and quality assurance via shinytest2 and related frameworks. The company positions itself as Posit (formerly RStudio) certified partner and maintains active participation in R Consortium and Pharmaverse working groups.

Team and credentials

Appsilon employs over 50 developers, biostatisticians, and scientists (exact count not disclosed, but "15,000+ applicants annually, 1% acceptance rate" suggests a selective, growing operation). Marcin Dubel leads technology. The team actively maintains open-source packages (Rhino, Tapyr, teal, aNCA) and contributes to industry standards through R Consortium and Pharmaverse. Certifications and partnerships include Posit certification, AWS partnership, Databricks integration, and alignment with GxP regulatory frameworks. The company does not publicly state ISO 27001, SOC 2, or other formal security certifications in the source material, though it emphasizes audit readiness in SCE documentation.